SOPHiA GENETICS SA (SOPH)
NMS · Healthcare · Health Information Services
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 18.3M | 19.5M | 21.7M | 21.7M |
| Gross Profit | 12.3M | 12.9M | 14.7M | 14.7M |
| Operating Income | -18.5M | -17.9M | -18.5M | -17.3M |
| Net Income | -22.4M | -20.0M | -19.2M | -19.3M |
| Diluted EPS | $-0.33 | $-0.30 | $-0.28 | $-0.27 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 47.6M | 62.4M | 65.2M | 77.3M |
| Gross Profit | 31.3M | 42.9M | 43.9M | 52.1M |
| Operating Income | -87.8M | -74.8M | -66.6M | -70.9M |
| Net Income | -87.4M | -79.0M | -62.5M | -79.0M |
| Diluted EPS | $-1.36 | $-1.22 | $-0.95 | $-1.17 |